The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenibLuca Faloppi, Stefano Cascinu, Maristella Bianconi et al.|Oncotarget|2015Cited by 46
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic ChemotherapyV. Fanotto, Giuseppe Aprile, Daniele Santini et al.|The Oncologist|2017Cited by 35
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic ChemotherapyV. Fanotto, Giuseppe Aprile, Mario Uccello et al.|The Oncologist|2018Cited by 8